CM
Castleark Management Portfolio holdings
AUM
$3.33B
1-Year Return
37.9%
This Quarter Return
-4.29%
1 Year Return
+37.9%
3 Year Return
+222.09%
5 Year Return
+481.09%
10 Year Return
+2,703.89%
AUM
$2.89B
AUM Growth
+$18.3M
(+0.64%)
Cap. Flow
+$213M
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
40.26%
Holding
355
New
72
Increased
84
Reduced
52
Closed
75
Top Buys
| 1 |
CastleArk Large Growth ETF
CARK
|
$295M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
$56.5M |
| 3 |
Invesco QQQ Trust
QQQ
|
$31.2M |
| 4 |
Eli Lilly
LLY
|
$30.5M |
| 5 |
Accenture
ACN
|
$18.5M |
Top Sells
| 1 |
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
$56.9M |
| 2 |
Apollo Global Management
APO
|
$37.5M |
| 3 |
Broadcom
AVGO
|
$35M |
| 4 |
Microsoft
MSFT
|
$24.1M |
| 5 |
Apple
AAPL
|
$16.4M |
Sector Composition
| 1 | Technology | 25.31% |
| 2 | Healthcare | 10.19% |
| 3 | Financials | 9.99% |
| 4 | Consumer Discretionary | 8.59% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EUAD
126
Select STOXX Europe Aerospace & Defense ETF
EUAD
$1.06B
| $4.93M | 0.17% |
+147,000
| New | +$4.93M |
|
127
The Ensign Group
ENSG
$10B
| $4.87M | 0.17% |
37,600
+850
| +2% | +$110K |
|
128
HSBC
HSBC
$227B
| $4.84M | 0.17% |
+84,200
| New | +$4.84M |
|
129
Krystal Biotech
KRYS
$4.35B
| $4.71M | 0.16% |
+26,120
| New | +$4.71M |
|
130
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $4.71M | 0.16% |
107,715
| – | – |
|
131
Citigroup
C
$176B
| $4.69M | 0.16% |
66,064
+62,220
| +1,619% | +$4.42M |
|
132
Shake Shack
SHAK
$4.03B
| $4.64M | 0.16% |
+52,630
| New | +$4.64M |
|
133
Associated Banc-Corp
ASB
$4.42B
| $4.47M | 0.16% |
198,520
+38,840
| +24% | +$875K |
|
134
Phreesia
PHR
$1.67B
| $4.31M | 0.15% |
+168,720
| New | +$4.31M |
|
135
GeneDx Holdings
WGS
$3.81B
| $4.23M | 0.15% |
47,810
-13,900
| -23% | -$1.23M |
|
136
Brink's
BCO
$4.78B
| $4.21M | 0.15% |
48,920
-28,010
| -36% | -$2.41M |
|
137
Mattel
MAT
$6.06B
| $4.21M | 0.15% |
+216,430
| New | +$4.21M |
|
138
Williams Companies
WMB
$69.9B
| $4.19M | 0.15% |
70,110
+44,540
| +174% | +$2.66M |
|
139
Catalyst Pharmaceutical
CPRX
$2.48B
| $4.17M | 0.14% |
+171,890
| New | +$4.17M |
|
140
Insmed
INSM
$30.7B
| $4.11M | 0.14% |
53,860
+1,080
| +2% | +$82.4K |
|
141
Penumbra
PEN
$11B
| $4.08M | 0.14% |
+15,245
| New | +$4.08M |
|
142
Fabrinet
FN
$13.2B
| $4.07M | 0.14% |
+20,590
| New | +$4.07M |
|
143
Royal Caribbean
RCL
$95.7B
| $4.05M | 0.14% |
+19,720
| New | +$4.05M |
|
144
Cheniere Energy
LNG
$51.8B
| $4M | 0.14% |
17,296
+330
| +2% | +$76.4K |
|
145
Littelfuse
LFUS
$6.51B
| $3.95M | 0.14% |
+20,080
| New | +$3.95M |
|
146
Tarsus Pharmaceuticals
TARS
$2.43B
| $3.85M | 0.13% |
+74,920
| New | +$3.85M |
|
147
Kratos Defense & Security Solutions
KTOS
$10.9B
| $3.84M | 0.13% |
+129,170
| New | +$3.84M |
|
148
MPLX
MPLX
$51.5B
| $3.75M | 0.13% |
70,132
-59,510
| -46% | -$3.18M |
|
149
BridgeBio Pharma
BBIO
$10.2B
| $3.7M | 0.13% |
+106,980
| New | +$3.7M |
|
150
Paymentus
PAY
$4.62B
| $3.7M | 0.13% |
141,650
+42,150
| +42% | +$1.1M |
|